tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

MDGL Stock Latest News

Madrigal Pharmaceuticals price target raised to $560 from $460 at B. Riley
The FlyMadrigal Pharmaceuticals price target raised to $560 from $460 at B. Riley
9d ago
MDGL
3 Stocks Showing Strong Buy Signals, According to Technical Analysis
PremiumMarket News
3 Stocks Showing Strong Buy Signals, According to Technical Analysis
14d ago
ALV
WAL
Madrigal Pharmaceuticals management to meet with B. Riley
PremiumThe Fly
Madrigal Pharmaceuticals management to meet with B. Riley
23d ago
MDGL
Madrigal Pharmaceuticals assumed with a Buy at H.C. Wainwright
PremiumThe Fly
Madrigal Pharmaceuticals assumed with a Buy at H.C. Wainwright
1M ago
MDGL
Madrigal Pharmaceuticals price target raised to $554 from $390 at TD Cowen
PremiumThe Fly
Madrigal Pharmaceuticals price target raised to $554 from $390 at TD Cowen
1M ago
MDGL
Madrigal Pharmaceuticals: Pioneering MASH Treatment with Rezdiffra’s European Market Breakthrough
PremiumRatingsMadrigal Pharmaceuticals: Pioneering MASH Treatment with Rezdiffra’s European Market Breakthrough
2M ago
MDGL
Madrigal Pharmaceuticals price target raised to $485 from $483 at Citizens JMP
Premium
The Fly
Madrigal Pharmaceuticals price target raised to $485 from $483 at Citizens JMP
2M ago
MDGL
Madrigal gets conditional marketing authorization for Rezdiffra from EC
Premium
The Fly
Madrigal gets conditional marketing authorization for Rezdiffra from EC
2M ago
MDGL
Buy Rating Affirmed for Madrigal Pharmaceuticals Amid Market Expansion Opportunities
PremiumRatings
Buy Rating Affirmed for Madrigal Pharmaceuticals Amid Market Expansion Opportunities
2M ago
MDGL
Novo Nordisk (NVO) Stock Gains as Wegovy Drug Gets FDA Nod for Liver Disease
PremiumMarket News
Novo Nordisk (NVO) Stock Gains as Wegovy Drug Gets FDA Nod for Liver Disease
2M ago
LLY
NVO
Madrigal Pharmaceuticals: Strong Buy Rating Backed by Rezdiffra’s Market Success and Strategic Expansion
PremiumRatings
Madrigal Pharmaceuticals: Strong Buy Rating Backed by Rezdiffra’s Market Success and Strategic Expansion
2M ago
MDGL
Madrigal Pharmaceuticals price target raised to $523 from $458 at UBS
PremiumThe Fly
Madrigal Pharmaceuticals price target raised to $523 from $458 at UBS
2M ago
MDGL
Madrigal Pharmaceuticals Reports Strong Growth Amid Challenges
PremiumCompany AnnouncementsMadrigal Pharmaceuticals Reports Strong Growth Amid Challenges
2M ago
MDGL
Madrigal Pharmaceuticals: Strategic Growth and Market Potential Driven by Rezdiffra’s Success and Key Acquisitions
Premium
Ratings
Madrigal Pharmaceuticals: Strategic Growth and Market Potential Driven by Rezdiffra’s Success and Key Acquisitions
2M ago
MDGL
Cautious Outlook on Madrigal Pharmaceuticals: Sell Rating Amid Competitive Pressures and Valuation Concerns
Premium
Ratings
Cautious Outlook on Madrigal Pharmaceuticals: Sell Rating Amid Competitive Pressures and Valuation Concerns
2M ago
MDGL
Madrigal Pharmaceuticals price target raised to $428 from $420 at Canaccord
PremiumThe Fly
Madrigal Pharmaceuticals price target raised to $428 from $420 at Canaccord
2M ago
MDGL
Madrigal Pharmaceuticals Reports Strong Q2 2025 Results
PremiumCompany Announcements
Madrigal Pharmaceuticals Reports Strong Q2 2025 Results
2M ago
MDGL
Madrigal Pharmaceuticals reports Q2 EPS ($1.90), consensus ($3.53)
PremiumThe Fly
Madrigal Pharmaceuticals reports Q2 EPS ($1.90), consensus ($3.53)
2M ago
MDGL
MDGL Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
MDGL Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
MDGL
Madrigal Pharmaceuticals Signs Global License Agreement
PremiumCompany AnnouncementsMadrigal Pharmaceuticals Signs Global License Agreement
2M ago
8K
MDGL
Madrigal Pharmaceuticals enters license pact with CSPC for SYH2086
Premium
The Fly
Madrigal Pharmaceuticals enters license pact with CSPC for SYH2086
2M ago
MDGL
Madrigal Pharmaceuticals: Strengthened Financial Position and Promising Pipeline Expansion Drive Buy Rating
Premium
Ratings
Madrigal Pharmaceuticals: Strengthened Financial Position and Promising Pipeline Expansion Drive Buy Rating
3M ago
MDGL

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >